Is Novo Nordisk stock a buy? An analysis of $NVO, its weight loss drugs Ozempic and Wegovy, and market share competition with Eli Lilly in August 2025.
novo nordisk stock analysis: ozempic, wegovy, and market share – august 2025
view original post